Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon alpha-2b dependent recalcitrant genital warts.

J Larsen1, C S Petersen, S Kroon

  • 1Department of Dermato-venereology, Bispebjerg Hospital, Copenhagen.

Danish Medical Bulletin
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Offshore solar farms as habitats for Mytilus edulis: A preliminary modelling study on mussel growth, distribution, chlorophyll-a uptake and bio-deposition in the North Sea.

Marine environmental research·2025
Same author

Evolution of Pulmonary Arteriovenous Malformations: The Role of Contrast Echocardiography.

Chest·2022
Same author

Benomyl inhibits phosphorus transport but not fungal alkaline phosphatase activity in a Glomus-cucumber symbiosis.

The New phytologist·2021
Same author

Use of Crotalidae equine immune F(ab')<sub>2</sub> antivenom for treatment of an <i>Agkistrodon</i> envenomation.

Clinical toxicology (Philadelphia, Pa.)·2021

Interferon alpha-2b effectively treated large, persistent penile warts resistant to other therapies. While the viral infection recurred after treatment cessation, systemic interferon suppressed the disease with mild toxicity.

Area of Science:

  • Dermatology
  • Virology
  • Immunology

Background:

  • Genital warts, often caused by human papillomavirus (HPV), can become large, disfiguring, and resistant to conventional treatments.
  • Therapeutic options for extensive or treatment-refractory genital warts are limited, posing a significant clinical challenge.

Observation:

  • A non-immunocompromised patient with aggressive, chronic, and disfiguring large penile warts, unresponsive to prior treatments, was administered interferon alpha-2b.
  • The interferon alpha-2b was administered subcutaneously at a dosage of 5 x 10^6 I.U. three times per week.

Findings:

  • Subcutaneous interferon alpha-2b therapy led to the flattening of large penile warts.
  • Discontinuation of therapy resulted in rapid recurrence of lesions, suggesting persistent underlying viral infection.

Related Experiment Videos

  • Systemic interferon therapy proved effective in suppressing the disease, despite recurrence upon cessation.
  • The treatment was associated with only transient and mild systemic toxicity.

    • Implications:

    • Subcutaneous interferon alpha-2b represents a potential therapeutic option for patients with large or disseminated genital warts that are resistant to other treatments.
    • This approach may offer a viable solution for managing otherwise intractable cases of genital warts.
    • Further investigation into the long-term efficacy and optimal use of interferon alpha-2b for resistant genital warts is warranted.